Dengue Fever

The microorganism responsible for Dengue fever is the Dengue virus (DENV).

Key facts:

It is a virus, not a bacterium or parasite.

It belongs to the Flavivirus family.

There are four main serotypes: DENV-1, DENV-2, DENV-3, and DENV-4.

The virus is transmitted to humans through the bite of infected Aedes aegypti mosquito and, less commonly, Aedes albopictus mosquito.

SAASKIN CORPORATION (CHENNAI)

For infectious disease management, speed and reliability are paramount. The Abbott Determine HIV-1/2 Rapid Card remains a cornerstone in POC testing, offering approximately 99.75% accuracy and results in 15 minutes. Similarly, the Abbott Dengue Duo provides crucial dual-detection of NS1 antigen and IgG/IgM antibodies, facilitating rapid intervention during active dengue outbreaks. In malaria-endemic regions, the Abbott Bioline Malaria Ag P.f/Pan test serves as an essential differential diagnostic tool to distinguish Plasmodium falciparum from other species. For deeper analysis, the Abbott Panbio Dengue ELISA is preferred in laboratory settings for its high specificity in distinguishing dengue infections from other flaviviruses.

Diagnosing dengue fever involves combining a person's symptoms, medical history, physical examination, and laboratory tests.

1. Clinical evaluation

A healthcare provider will ask about:

Recent fever (especially a sudden high fever)

Recent travel to or residence in an area where dengue is common

Exposure to mosquitoes

SAASKIN CORPORATION (CHENNAI)

The Abbott Determine™ HIV-1/2 is a qualitative immunoassay designed for the simultaneous detection of antibodies to HIV-1 and HIV-2. Whether used in a high-traffic urban hospital or a remote rural clinic, this test provides results in just 15 minutes. Its versatility is one of its strongest selling points, as it is compatible with multiple sample types: Serum, Plasma, Whole Blood (Finger stick or Venipuncture) With a proven accuracy rate of approximately 99.75%, it ensures that healthcare professionals can make informed decisions quickly, facilitating immediate linkage to care for those who test reactive.

For most dengue blood tests (NS1 antigen, IgM, IgG, ELISA, or rapid tests), the sample is usually collected in a plain red-top tube or a yellow/gold serum separator tube (SST) because the test is performed on serum.

SAASKIN CORPORATION (CHENNAI)

The Abbott Determine™ HIV-1/2 is a qualitative immunoassay designed for the simultaneous detection of antibodies to HIV-1 and HIV-2. Whether used in a high-traffic urban hospital or a remote rural clinic, this test provides results in just 15 minutes. Its versatility is one of its strongest selling points, as it is compatible with multiple sample types: Serum, Plasma, Whole Blood (Finger stick or Venipuncture) With a proven accuracy rate of approximately 99.75%, it ensures that healthcare professionals can make informed decisions quickly, facilitating immediate linkage to care for those who test reactive. Key Features &

Dengue Duo is a rapid diagnostic test used to help detect dengue fever. It typically tests for two markers:

NS1 Antigen – Usually detectable during the first few days of illness (often days 1–7 after symptoms start).

IgM/IgG Antibodies – These are produced by the body's immune system and generally become detectable later in the infection.

SAASKIN CORPORATION (CHENNAI)

The Abbott Determine™ HIV-1/2 is a qualitative immunoassay designed for the simultaneous detection of antibodies to HIV-1 and HIV-2. Whether used in a high-traffic urban hospital or a remote rural clinic, this test provides results in just 15 minutes. Its versatility is one of its strongest selling points, as it is compatible with multiple sample types: Serum, Plasma, Whole Blood (Finger stick or Venipuncture) With a proven accuracy rate of approximately 99.75%, it ensures that healthcare professionals can make informed decisions quickly, facilitating immediate linkage to care for those who test reactive. Key Features &

In the fancy dress competition, the dengue mac-char struts onto the stage, flaring its iridescent wings and buzzing playfully. It exclaims, “I may be small, but I’m a big problem! Let’s raise awareness and fight dengue together, because prevention is the best protection!” With a cheeky grin, it adds, “Remember to cover up, stay safe, and let’s keep those mosquitoes at bay!”

Pantoprazole is not specifically indicated for treating dengue fever; however, it may be prescribed to manage gastrointestinal symptoms, such as nausea or gastritis, that can occur during the illness. Dengue can lead to increased acidity or stomach irritation, and pantoprazole, a proton pump inhibitor, helps reduce stomach acid production. This can provide symptomatic relief to patients experiencing discomfort. Nonetheless, it is essential to focus on proper hydration and supportive care in dengue management.

Dengue fever is often identified by symptoms such as a high fever, severe headache, pain behind the eyes, joint and muscle pain, rash, and mild bleeding. If you experience these symptoms, especially after traveling to areas where dengue is common, it’s important to seek medical attention. A healthcare provider can confirm the diagnosis through blood tests that detect the virus or antibodies. Early detection and proper management are crucial to prevent complications.

The cost of a dengue fever check-up can vary widely depending on the location and healthcare provider. Generally, it may range from $20 to $100 in many countries for a basic consultation and blood tests. In some regions, especially where dengue is endemic, government health facilities may offer these services at lower or no cost. It's best to check with local health services for specific pricing.

Dengue disease is caused by the dengue virus, which is transmitted primarily through the bites of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus. The virus can also be spread through blood transfusions, organ transplants, and from mother to child during pregnancy or childbirth. Factors contributing to dengue outbreaks include urbanization, inadequate water management, and poor mosquito control measures, as these conditions favor mosquito breeding. Climate change also plays a role by expanding the habitats of these mosquitoes.

Thrombocytopenia in dengue is primarily due to several factors, including bone marrow suppression, increased platelet destruction, and consumption. The dengue virus can directly infect bone marrow cells, leading to decreased platelet production. Additionally, the immune response to the virus may cause the body to produce antibodies that mistakenly target and destroy platelets. Lastly, increased vascular permeability associated with dengue can lead to platelet sequestration in the spleen.

Yes, dengue fever is considered an acute disease. It is characterized by a sudden onset of symptoms, including high fever, severe headaches, joint and muscle pain, and rash. The illness typically lasts for about one to two weeks, with most patients recovering fully, although severe cases can lead to complications and require medical attention.

Dengue patients may vomit blood due to severe complications associated with the disease, such as hemorrhagic manifestations. This occurs when the dengue virus damages blood vessels, leading to increased permeability and bleeding. Additionally, severe liver damage and a drop in platelet counts can exacerbate bleeding risks. If a patient experiences this symptom, it is a sign of a serious condition requiring immediate medical attention.

In the context of dengue, a "reactive result" typically refers to a positive finding in laboratory tests, indicating the presence of antibodies or viral RNA associated with the dengue virus. This means that the individual has likely been infected with dengue at some point, either currently or in the past. Reactive results can guide healthcare providers in diagnosing and managing the patient's condition, although further testing may be needed to confirm the active infection and assess its severity.

In dengue fever, the liver is affected due to the virus's ability to replicate within liver cells, leading to inflammation and damage. The immune response to the infection can also contribute to liver injury, as the body releases cytokines that can exacerbate inflammation. This hepatic involvement may result in elevated liver enzymes and, in severe cases, contribute to complications such as liver failure. Monitoring liver function is important in managing dengue patients.

Dengue virus primarily affects immune cells, particularly macrophages and dendritic cells, which are key components of the immune response. The virus can also impact endothelial cells lining blood vessels, leading to increased vascular permeability and contributing to symptoms like bleeding and plasma leakage. Additionally, liver cells may be affected, resulting in liver dysfunction in severe cases. Overall, the systemic nature of dengue can lead to widespread tissue involvement.

Yes, Dengue Fever can be considered an OSHA recordable illness if a worker contracts it as a result of their job duties, particularly if it's linked to a work-related exposure, such as being bitten by infected mosquitoes while on duty. Employers are required to record work-related illnesses on their OSHA 300 log, which includes any significant health issues that arise due to workplace conditions. However, if the illness is not work-related, it would not be recordable. Each case should be evaluated based on the specifics of the exposure and circumstances.

The case fatality rate for dengue fever varies by region and the specific outbreak but generally ranges from less than 1% to about 5% for severe cases. In most cases, dengue is self-limiting, and fatalities are relatively rare, especially with proper medical care. It's important to note that many infections are mild and undiagnosed, so the percentage of deaths among all infected individuals is likely much lower. Public health initiatives have significantly reduced dengue-related mortality in many areas.

Typhoid fever primarily affects the gastrointestinal system and can lead to severe physical symptoms, but it can also have psychological effects. Some patients may experience confusion, delirium, or changes in mental status due to high fever, dehydration, or complications from the infection. Additionally, the stress of illness and recovery can contribute to anxiety or depression. However, typhoid fever itself does not directly cause chronic mental illness.

Yes, paracetamol (acetaminophen) is commonly used to reduce fever and alleviate pain associated with dengue fever. It is preferred over non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or aspirin, as these can increase the risk of bleeding, a potential complication of dengue. However, it's essential to consult a healthcare professional for proper management and treatment recommendations.

If you have an acetaminophen allergy and are experiencing dengue fever, it's important to avoid acetaminophen-based medications for pain and fever relief. Instead, you can consider using nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, but consult your healthcare provider first, as they may have specific recommendations based on your health status. Hydration and rest are also crucial in managing dengue. Always seek medical advice for appropriate treatment options tailored to your situation.

In dengue patients, elevated levels of serum glutamate-pyruvate transaminase (SGPT) and serum glutamate-oxaloacetate transaminase (SGOT) are often indicative of liver involvement, which can occur due to direct viral invasion of liver cells or as a result of immune-mediated liver injury. The release of these enzymes into the bloodstream is a response to liver cell damage, which can be exacerbated by factors such as hypoxia, dehydration, and coagulopathy associated with severe dengue. Monitoring these enzyme levels helps assess the severity of liver impairment and overall disease progression in dengue patients.

Dengue fever in Costa Rica is worsening due to several factors, including increased urbanization that creates breeding grounds for mosquitoes, particularly Aedes aegypti, which transmit the virus. Climate change also plays a role by extending the mosquito breeding season and increasing their range. Additionally, public health challenges such as inadequate vector control measures and a lack of community awareness contribute to the rising incidence of the disease. Efforts to manage and mitigate outbreaks are further complicated by resource constraints and the need for improved surveillance systems.

The virus that causes dengue is called the dengue virus (DENV). It belongs to the Flavivirus genus and has four distinct serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. Dengue virus is primarily transmitted to humans through the bites of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus. Infection can lead to dengue fever, which can range from mild to severe.

Dengue virus causes internal bleeding primarily through its effects on the vascular system. The virus infects and damages endothelial cells lining blood vessels, leading to increased permeability and leakage of plasma into surrounding tissues. This results in a drop in blood volume and can cause hemorrhagic manifestations. Additionally, the immune response to the virus may further exacerbate vascular damage, contributing to the severity of bleeding complications in dengue hemorrhagic fever.

Menorrhagia, or heavy menstrual bleeding, can occur in dengue fever due to the virus's impact on the body, particularly its effects on blood platelets and the coagulation system. Dengue can lead to thrombocytopenia (low platelet count), which increases the risk of bleeding, including during menstruation. Additionally, the inflammatory response and vascular changes associated with the infection may exacerbate menstrual bleeding. Thus, women with dengue may experience heavier periods as a result of these factors.